T cell responses to HLA-A* 0201-restricted peptides derived from human α fetoprotein

Journal of Immunology

Volumn 166, Issue 8, 2001, Pages 5300-5308

  Butterfield, L H ^a   Meng, W S ^a   Koh, A ^a   Vollmer, C M ^a   Ribas, A ^a   Dissette, V B ^a   Faull, K ^a   Glaspy, J A ^a   McBride, W H ^a   Economou, J S ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; IMMUNOGENICITY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0035871639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.8.5300     Document Type: Article

References (32)

1. Hepatucellular carcinoma
2. Generation of human T cell responses to an HLA-A2.1-restricted peptide epitope from a fetoprotein
3. α-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma
4. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles
5. Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions
6. In vivo cancer gene therapy with a recombinant interleukin-2 adenovims vector
7. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay
8. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes
9. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells: Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301
10. Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood
11. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovims
12. A comparison of gene transfer methods in human dendritic cells
13. Proliferating dendritic cell progenitors in human blood
14. A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides
15. Detection and quantification of blood-derived CDS+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens
16. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
17. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovims-transduced murine dendritic cells
18. Identification of T-cell epitopes: Rapid isolation of class I-presented peptides from viable cells by mild acid elution
19. Consensus motifs and peptide ligands of MHC class I molecules
20. MHC molecules as peptide receptors
21. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
22. Dominance and crypticity of T cell antigenic determinants
23. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice
24. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
25. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb
26. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC
27. T cell activation determined by T cell receptor number and tunable thresholds
28. Serial triggering of many T-cell receptors by a few peptide-MHC complexes
29. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte
30. Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides
31. Comparison of cytotoxic T-lymphocyte responses to hepatitis C vires core protein in uninfected and infected individuals